Literature DB >> 24889040

Impaired glycemia and Alzheimer's disease.

Jill K Morris1, Eric D Vidoni2, Robyn A Honea2, Jeffrey M Burns2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24889040      PMCID： PMC4251461          DOI： 10.1016/j.neurobiolaging.2014.04.018

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN： 0197-4580            Impact factor:   4.673


× No keyword cloud information.
  5 in total

1.  Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.

Authors:  T Matsuzaki; K Sasaki; Y Tanizaki; J Hata; K Fujimi; Y Matsui; A Sekita; S O Suzuki; S Kanba; Y Kiyohara; T Iwaki
Journal:  Neurology       Date:  2010-08-25       Impact factor: 9.910

2.  Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6-year observation in the Japanese Elderly Diabetes Intervention Trial.

Authors:  Hiroyuki Umegaki; Satoshi Iimuro; Tomohiro Shinozaki; Atsushi Araki; Takashi Sakurai; Katsuya Iijima; Yasuo Ohashi; Hideki Ito
Journal:  Geriatr Gerontol Int       Date:  2012-04       Impact factor: 2.730

3.  Impaired glycemia increases disease progression in mild cognitive impairment.

Authors:  Jill K Morris; Eric D Vidoni; Robyn A Honea; Jeffrey M Burns
Journal:  Neurobiol Aging       Date:  2013-10-23       Impact factor: 4.673

4.  Multisite comparison of high-sensitivity multiplex cytokine assays.

Authors:  Elizabeth Crabb Breen; Sandra M Reynolds; Christopher Cox; Lisa P Jacobson; Larry Magpantay; Candice B Mulder; Oliver Dibben; Joseph B Margolick; Jay H Bream; Elise Sambrano; Otoniel Martínez-Maza; Elizabeth Sinclair; Persephone Borrow; Alan L Landay; Charles R Rinaldo; Philip J Norris
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

5.  Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.

Authors:  Madhav Thambisetty; E Jeffrey Metter; An Yang; Hillary Dolan; Christopher Marano; Alan B Zonderman; Juan C Troncoso; Yun Zhou; Dean F Wong; Luigi Ferrucci; Josephine Egan; Susan M Resnick; Richard J O'Brien
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302
  5 in total
  4 in total

1.  PPARγ agonists regulate bidirectional transport of amyloid-β across the blood-brain barrier and hippocampus plasticity in db/db mice.

Authors:  Hao Wang; Fang Chen; Kai Long Zhong; Su Su Tang; Mei Hu; Yan Long; Ming Xing Miao; Jian Min Liao; Hong Bing Sun; Hao Hong
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

Review 2.  A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.

Authors:  Patrizia Mecocci; Virginia Boccardi; Roberta Cecchetti; Patrizia Bastiani; Michela Scamosci; Carmelinda Ruggiero; Marta Baroni
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 3.  Apolipoprotein E and Alzheimer's disease.

Authors:  Benjamin R Troutwine; Laylan Hamid; Colton R Lysaker; Taylor A Strope; Heather M Wilkins
Journal:  Acta Pharm Sin B       Date:  2021-10-15       Impact factor: 11.413

4.  Editorial: Metabolism in Alzheimer's Disease.

Authors:  Jill K Morris; Levi B Wood; Heather M Wilkins
Journal:  Front Neurosci       Date:  2022-01-04       Impact factor: 4.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.